Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ELTP
$0.25
-0.12%
ELTP
· Elite Pharmaceuticals Inc
$0.25
0.00 (-0.12%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$269.28M
Shares
1.08B
Volume · Oct 21
223.38K
Avg daily vol (3M)
771.66K
All webcasts
Earnings call · FY2025 Q2
Elite Pharmaceuticals Inc (ELTP) Q2 2025 Earnings Call
Revenue
$18.88M
+33.4% YoY
Diluted EPS
-$0.01
-200% YoY
Gross margin
43.4%
-2.1 pp YoY
Net income
-$11.04M
-173.9% YoY
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 14, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2024 · complete as-filed document